Sign Up Today and Learn More About Noveome Biotherapeutics Stock
Invest in or calculate the value of your shares in Noveome Biotherapeutics or other pre-IPO companies through EquityZen's platform.
Noveome Biotherapeutics Stock (NOBI)
Noveome Biotherapeutics focuses on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.
About Noveome Biotherapeutics Stock
Founded
2000
Headquarters
Pittsburgh, PA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Noveome Biotherapeutics Press Mentions
Stay in the know about the latest news on Noveome Biotherapeutics
Noveome Biotherapeutics Announces Issuance of U.S. Patent No. 12,121,546 “Treatment of Systemic Inflammatory Responses”
einpresswire • Nov 20, 2024
Noveome Biotherapeutics Completes Dosing of First Baby in Clinical Trial for Treatment of Necrotizing Enterocolitis
einpresswire • Nov 15, 2024
Secretome fractions and uses thereof
patents • Apr 14, 2024
Use of st266 to treat severe systemic inflammation and post-acute covid-19 …
patents • Apr 14, 2024
Treatment of Systemic Inflammatory Responses
patents • Apr 14, 2024
Noveome Biotherapeutics Management
Leadership team at Noveome Biotherapeutics
Executive VP of Medical Affairs, Chief Medical Officer
David Steed
Executive Vice President and Chief Scientific Officer
Larry Brown
Join now and verify your accreditation status to gain access to:
- Noveome Biotherapeutics current valuation
- Noveome Biotherapeutics stock price
- Available deals in Noveome Biotherapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Noveome Biotherapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Noveome Biotherapeutics through EquityZen funds. These investments are made available by existing Noveome Biotherapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Noveome Biotherapeutics stock?
Shareholders can sell their Noveome Biotherapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
